Free Trial

Acasti Pharma (ACST) SEC Filings & 10K Form

$2.60
-0.12 (-4.41%)
(As of 02:08 PM ET)

Recent Acasti Pharma SEC Filings

DateFilerForm TypeView
05/08/2024
6:18 PM
Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:18 PM
Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
7:46 AM
Acasti Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G
04/01/2024
7:00 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
6:03 PM
Acasti Pharma (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
Form SC 13G
02/12/2024
7:00 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:30 AM
Acasti Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/08/2024
7:00 AM
Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2024
6:30 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:30 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:10 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:30 AM
Acasti Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2023
3:30 PM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
11:21 AM
Acasti Pharma (Issuer)
DAVIS A BRIAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/20/2023
11:22 AM
Acasti Pharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/20/2023
11:23 AM
Acasti Pharma (Issuer)
Kottayil George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
11:15 PM
Acasti Pharma (Filer)
Form EFFECT
10/16/2023
3:31 PM
Acasti Pharma (Filer)
Form 424B3
10/11/2023
3:30 PM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
6:40 AM
Acasti Pharma (Filer)
Form D
Notice of Exempt Offering of Securities 
10/06/2023
3:30 PM
Acasti Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/27/2023
6:46 PM
Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
7:10 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
4:01 PM
Acasti Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/25/2023
3:15 PM
Acasti Pharma (Filer)
Form DEF 14A
08/25/2023
3:21 PM
Acasti Pharma (Filer)
Form DEFA14A
08/11/2023
6:31 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
6:15 AM
Acasti Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2023
4:30 PM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
3:32 PM
Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:34 PM
Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:36 PM
Acasti Pharma (Issuer)
Olds Donald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:36 PM
Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:37 PM
Acasti Pharma (Issuer)
Derby Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:26 PM
Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:28 PM
Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
7:30 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
6:31 AM
Acasti Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Log Into Marc's $5,000 System Today (Ad)

New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024.

More here.
06/23/2023
6:01 AM
Acasti Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACST) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners